BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8676469)

  • 1. A role for urokinase-type plasminogen activator in human immunodeficiency virus type 1 infection of macrophages.
    Handley MA; Steigbigel RT; Morrison SA
    J Virol; 1996 Jul; 70(7):4451-6. PubMed ID: 8676469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid substitutions in the human immunodeficiency virus type 1 gp120 V3 loop that change viral tropism also alter physical and functional properties of the virion envelope.
    Willey RL; Theodore TS; Martin MA
    J Virol; 1994 Jul; 68(7):4409-19. PubMed ID: 7515973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus type 1 IIIB selected for replication in vivo exhibits increased envelope glycoproteins in virions without alteration in coreceptor usage: separation of in vivo replication from macrophage tropism.
    Miller ED; Duus KM; Townsend M; Yi Y; Collman R; Reitz M; Su L
    J Virol; 2001 Sep; 75(18):8498-506. PubMed ID: 11507195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection of primary human microglia and monocyte-derived macrophages with human immunodeficiency virus type 1 isolates: evidence of differential tropism.
    Strizki JM; Albright AV; Sheng H; O'Connor M; Perrin L; González-Scarano F
    J Virol; 1996 Nov; 70(11):7654-62. PubMed ID: 8892885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread.
    Toohey K; Wehrly K; Nishio J; Perryman S; Chesebro B
    Virology; 1995 Oct; 213(1):70-9. PubMed ID: 7483281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of naturally occurring basic amino acid substitutions in the human immunodeficiency virus type 1 subtype E envelope V3 loop on viral coreceptor usage and cell tropism.
    Kato K; Sato H; Takebe Y
    J Virol; 1999 Jul; 73(7):5520-6. PubMed ID: 10364300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?
    Clements GJ; Price-Jones MJ; Stephens PE; Sutton C; Schulz TF; Clapham PR; McKeating JA; McClure MO; Thomson S; Marsh M
    AIDS Res Hum Retroviruses; 1991 Jan; 7(1):3-16. PubMed ID: 2015114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of human immunodeficiency virus type 1 envelope glycoprotein V3 loop with CCR5 and CD4 at the membrane of human primary macrophages.
    Rabehi L; Seddiki N; Benjouad A; Gluckman JC; Gattegno L
    AIDS Res Hum Retroviruses; 1998 Dec; 14(18):1605-15. PubMed ID: 9870313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-tropic human immunodeficiency virus type 1 (HIV-1)-derived V3 loop peptides directly bind to CXCR-4 and inhibit T-tropic HIV-1 infection.
    Sakaida H; Hori T; Yonezawa A; Sato A; Isaka Y; Yoshie O; Hattori T; Uchiyama T
    J Virol; 1998 Dec; 72(12):9763-70. PubMed ID: 9811711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct role of plasma membrane-expressed gp120/41 in toxicity to human astrocytes induced by HIV-1-infected macrophages.
    Boutet A; Altmeyer R; Héry C; Tardieu M
    AIDS; 2000 Dec; 14(17):2687-97. PubMed ID: 11125887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-engaged urokinase-type plasminogen activator receptor and activation of the CD11b/CD18 integrin inhibit late events of HIV expression in monocytic cells.
    Alfano M; Mariani SA; Elia C; Pardi R; Blasi F; Poli G
    Blood; 2009 Feb; 113(8):1699-709. PubMed ID: 18941116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
    Quitadamo B; Peters PJ; Repik A; O'Connell O; Mou Z; Koch M; Somasundaran M; Brody R; Luzuriaga K; Wallace A; Wang S; Lu S; McCauley S; Luban J; Duenas-Decamp M; Gonzalez-Perez MP; Clapham PR
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urokinase plasminogen activator inhibits HIV virion release from macrophage-differentiated chronically infected cells via activation of RhoA and PKCε.
    Graziano F; Elia C; Laudanna C; Poli G; Alfano M
    PLoS One; 2011; 6(8):e23674. PubMed ID: 21858203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A monoclonal antibody (12G5) directed against CXCR-4 inhibits infection with the dual-tropic human immunodeficiency virus type 1 isolate HIV-1(89.6) but not the T-tropic isolate HIV-1(HxB).
    Strizki JM; Turner JD; Collman RG; Hoxie J; González-Scarano F
    J Virol; 1997 Jul; 71(7):5678-83. PubMed ID: 9188648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-10 inhibits initial reverse transcription of human immunodeficiency virus type 1 and mediates a virostatic latent state in primary blood-derived human macrophages in vitro.
    Montaner LJ; Griffin P; Gordon S
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3393-400. PubMed ID: 7527834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brucella abortus conjugated with a gp120 or V3 loop peptide derived from human immunodeficiency virus (HIV) type 1 induces neutralizing anti-HIV antibodies, and the V3-B. abortus conjugate is effective even after CD4+ T-cell depletion.
    Golding B; Inman J; Highet P; Blackburn R; Manischewitz J; Blyveis N; Angus RD; Golding H
    J Virol; 1995 Jun; 69(6):3299-307. PubMed ID: 7745677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans.
    Moore JP; Ho DD
    J Virol; 1993 Feb; 67(2):863-75. PubMed ID: 7678308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A post-CD4-binding step involving interaction of the V3 region of viral gp120 with host cell surface glycosphingolipids is common to entry and infection by diverse HIV-1 strains.
    Nehete PN; Vela EM; Hossain MM; Sarkar AK; Yahi N; Fantini J; Sastry KJ
    Antiviral Res; 2002 Dec; 56(3):233-51. PubMed ID: 12406507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular proteases involved in the pathogenicity of enveloped animal viruses, human immunodeficiency virus, influenza virus A and Sendai virus.
    Kido H; Niwa Y; Beppu Y; Towatari T
    Adv Enzyme Regul; 1996; 36():325-47. PubMed ID: 8869754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in and discrepancies between cell tropisms and coreceptor uses of human immunodeficiency virus type 1 induced by single point mutations at the V3 tip of the env protein.
    Shimizu N; Haraguchi Y; Takeuchi Y; Soda Y; Kanbe K; Hoshino H
    Virology; 1999 Jul; 259(2):324-33. PubMed ID: 10388657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.